資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/31690
|
| 標題: | Cisplatin Nephrotoxicity Might Have a Sex Difference. An analysis Based on Women's Sex Hormone Changes |
| 作者: | Chen, Wei-Yu
Hsiao, Ching-Hsing
Chen, Yi-Chen
Ho, Chung-Han
Wang, Jhi-Joung
Hsing, Chung-Hsi
Wang, Hsien-Yi
Kan, Wei-Chih
Wu, Chia-Chun |
| 貢獻者: | Chi Mei Med Ctr, Dept Hematol & Oncol
Chi Mei Hosp, Dept Ophthalmol
Chi Mei Med Ctr, Dept Med Res
Chia Nan Univ Pharm & Sci, Dept Pharm
Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
Chi Mei Med Ctr, Dept Med Res
Chi Mei Med Ctr, Dept Anesthesiol
Taipei Med Univ, Dept Anesthesiol, Coll Med
Chi Mei Med Ctr, Dept Nephrol, Dept Internal Med
Chia Nan Univ Pharm & Sci, Dept Sports Management, Coll Leisure & Recreat Management
Chung Hwa Univ Med Technol, Dept Biol Sci & Technol |
| 關鍵字: | cisplatin
nephrotoxicity
sex difference
chronic kidney disease
acute kidney disease |
| 日期: | 2017 |
| 上傳時間: | 2018-11-30 15:53:01 (UTC+8) |
| 出版者: | Ivyspring Int Publ |
| 摘要: | Background: A sex difference in cisplatin-induced nephrotoxicity (CIN) has been reported in human and animal studies. We examined in humans whether it is associated with sex-hormone changes. Methods: In this retrospective nationwide cohort study, we used Taiwan's National Health Insurance Research Database (NHIRD) to identify patients with a history of malignancy and cisplatin treatment. Patients diagnosed with kidney disease before cisplatin treatment and those with sex-organ malignancies were excluded. A diagnosis of kidney disease within 90 days after the first administration of cisplatin was the study outcome. Risk factors were estimated using a Cox regression model. Subgroup analyses were performed based on different women's estrogen levels in phases of childbearing, perimenopause, and postmenopause. Results: A retrospective analysis of the records of 3973 men (mean age: 56.15 +/- 12.85 years) and 1154 women (mean age: 56.31 +/- 12.40 years) showed that 1468 (36.95%) men and 451 (39.08%) women had a new diagnosis of kidney disease. The risk factors were being > 55 years old, a high comorbidity score, and a history of aminoglycoside treatment. Only postmenopausal women had a significantly higher risk of kidney injury (hazard ratio: 1.28; 95% CI: 1.02-1.61) than did men. Conclusions: Perimenopausal women have a significantly higher risk of CIN than do men, which might be explained by women's higher levels of estrogen. Additional studies on the underlying mechanisms of the sex difference of CIN are needed. |
| 關聯: | Journal of Cancer, v.8, n.19, pp.3939-3944 |
| 顯示於類別: | [醫務管理系(所)] 期刊論文
[藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1548 | 檢視/開啟 | | jca.20083.pdf | | 410Kb | Adobe PDF | 0 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
